Production of anti-inflammatory cytokines

“Production of anti-inflammatory cytokines” refers to a **biological process** in which certain cells—primarily immune cells such as T helper 2 cells, regulatory T cells, macrophages, and others—secrete proteins known as **anti-inflammatory cytokines**. These molecules include interleukin 4 (IL‑4), interleukin 10 (IL‑10), interleukin 13 (IL‑13), transforming growth factor beta (TGF‑β), and others. Their main function is to counteract proinflammatory signals in order to resolve inflammation and restore tissue homeostasis after an immune response[2][3][9]. This process is essential for preventing excessive tissue damage due to prolonged inflammation and for maintaining proper immune system balance. However, “production of anti-inflammatory cytokines” is not itself a molecular entity or therapeutic target like a receptor or enzyme; rather it describes an outcome regulated by multiple signaling pathways and cellular interactions. Note: The entry “Production of anti-inflammatory cytokines” does not correspond to any single molecule/receptor/protein but instead denotes a physiological event involving several different molecules. Therefore: is_incorrect = true — This entry should not be treated as a canonical therapeutic target but rather as an important immunological concept/process. For structured data purposes focused on drug targets or biomolecules, this should be replaced with entries for individual well-defined targets such as "Interleukin 10", "Transforming growth factor beta", etc.[3][9]

Other names

Anti-inflammatory cytokine productionInduction of anti-inflammatory cytokinesCytokine-mediated immunosuppression